GB202110228D0 - Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping - Google Patents

Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping

Info

Publication number
GB202110228D0
GB202110228D0 GBGB2110228.0A GB202110228A GB202110228D0 GB 202110228 D0 GB202110228 D0 GB 202110228D0 GB 202110228 A GB202110228 A GB 202110228A GB 202110228 D0 GB202110228 D0 GB 202110228D0
Authority
GB
United Kingdom
Prior art keywords
compositions
preventing
methods
overactive bladder
treating incontinence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB2110228.0A
Other versions
GB2595089B (en
GB2595089A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbasian Behnam
Kimberly Clark Worldwide Inc
Kimberly Clark Corp
Original Assignee
Abbasian Behnam
Kimberly Clark Worldwide Inc
Kimberly Clark Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbasian Behnam, Kimberly Clark Worldwide Inc, Kimberly Clark Corp filed Critical Abbasian Behnam
Publication of GB202110228D0 publication Critical patent/GB202110228D0/en
Publication of GB2595089A publication Critical patent/GB2595089A/en
Application granted granted Critical
Publication of GB2595089B publication Critical patent/GB2595089B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/36—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB2110228.0A 2018-12-21 2019-12-20 Compositions for use in methods for preventing or treating incontinence, overactive bladder, or menstrual cramping Active GB2595089B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862783465P 2018-12-21 2018-12-21
PCT/US2019/067789 WO2020132411A1 (en) 2018-12-21 2019-12-20 Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping

Publications (3)

Publication Number Publication Date
GB202110228D0 true GB202110228D0 (en) 2021-09-01
GB2595089A GB2595089A (en) 2021-11-17
GB2595089B GB2595089B (en) 2023-02-15

Family

ID=71101642

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2110228.0A Active GB2595089B (en) 2018-12-21 2019-12-20 Compositions for use in methods for preventing or treating incontinence, overactive bladder, or menstrual cramping

Country Status (8)

Country Link
US (1) US20220062356A1 (en)
KR (1) KR20210141920A (en)
CN (1) CN113164534A (en)
AU (1) AU2019404345A1 (en)
BR (1) BR112021010631A2 (en)
GB (1) GB2595089B (en)
MX (1) MX2021006759A (en)
WO (1) WO2020132411A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI802077B (en) * 2021-11-12 2023-05-11 葡萄王生技股份有限公司 Complex probiotic composition for alleviating overactive bladder syndrome and use thereof
CN116515686B (en) * 2023-03-31 2023-10-31 江苏科荣生物医药有限公司 Lactobacillus crispatus for treating female reproductive infection and regulating premenstrual psychological symptoms and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
SE528382C2 (en) * 2004-10-05 2006-10-31 Probi Ab Probiotic lactobacillus strains for improved vaginal health
SG190719A1 (en) * 2010-11-29 2013-07-31 Meiji Co Ltd Endometriosis prevention and/or improving agent, and food or drink composition containing same
WO2016064643A1 (en) * 2014-10-24 2016-04-28 University Of Florida Research Foundation, Incorporated Lactobacillus acidophilus surface layer protein a (slpa) as a therapeutic agent for the treatment of inflammatory diseases
CN104839682A (en) * 2015-04-14 2015-08-19 劲膳美生物科技股份有限公司 Medical formula food used for women menopause delaying and conditioning
CN107668458A (en) * 2017-09-19 2018-02-09 华南农业大学 A kind of solid beverage for improving menalgia

Also Published As

Publication number Publication date
US20220062356A1 (en) 2022-03-03
AU2019404345A1 (en) 2021-08-05
BR112021010631A2 (en) 2021-08-24
KR20210141920A (en) 2021-11-23
MX2021006759A (en) 2021-09-28
GB2595089B (en) 2023-02-15
WO2020132411A1 (en) 2020-06-25
GB2595089A (en) 2021-11-17
CN113164534A (en) 2021-07-23

Similar Documents

Publication Publication Date Title
IL285072A (en) Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders
ZA202207394B (en) Compositions and methods for treating hemoglobinopathies
EP3634424A4 (en) Compositions and methods for preventing or treating muscle conditions
IL282375A (en) 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating α-synucleinopathies, tauopathies, and other disorders
EP3801477A4 (en) Methods and compositions for preventing or treating tissue calcification
EP3829299A4 (en) Bismuth-thiol compositions and methods for treating wounds
IL285886A (en) Compositions and methods for treating laminopathies
ZA202101362B (en) Compositions and methods for treating the eye
EP3801478A4 (en) Methods and compositions for preventing or treating calciphylaxis
EP3784330A4 (en) Devices, systems, and methods for treating urinary and fecal incontinence
GB202110228D0 (en) Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping
EP3893785A4 (en) Compositions and methods for treating wounds
EP3760215A4 (en) Composition for preventing, alleviating, or treating cachexia and muscle loss
IL288440A (en) Compositions and methods for treating retinopathy
EP3781154A4 (en) Compositions and methods for treating renal injury
EP3737370A4 (en) Compositions and methods for treating pain with wogonin
ZA202007183B (en) Compositions and methods for treating the eye
ZA202101360B (en) Compositions and methods for treating the eye
ZA202101361B (en) Compositions and methods for treating the eye
EP3990394A4 (en) Compositions and methods for treating wastewater
EP3826980A4 (en) Composition and method for treating urea
IL292186A (en) Compositions and methods for treating blood disorders
IL285796A (en) Methods and compositions for treating
IL288478A (en) Methods, compositions and devices for treating neuroinflammatory conditions
IL271180A (en) Methods for preventing and treating urinary incontinence